Evidence map›Paper›PMID 39610527›Full record

ReviewJournal of diabetes and metabolic disorders2024

Genetic research in Immunogenetics Group of Endocrinology and Metabolism Research Institute.

Saeedeh Asgarbeik, Mahsa M Amoli, Aida Vahidi, Zeynab Nickhah Klashami

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of diabetes and metabolic disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Saeedeh AsgarbeikMetabolic Disorders Research Center, Endocrinology and Metabolism Molecular Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-2546-3290
Mahsa M AmoliMetabolic Disorders Research Center, Endocrinology and Metabolism Molecular Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-9168-9223
Aida VahidiMetabolic Disorders Research Center, Endocrinology and Metabolism Molecular Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-4727-9446
Zeynab Nickhah KlashamiMetabolic Disorders Research Center, Endocrinology and Metabolism Molecular Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-6241-0692

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the high prevalence of metabolic diseases and the role of genetic factors in their susceptibility, the use of basic research in this field can be useful for screening, prevention, and treatment of metabolic disorders. Therefore, in the Immunogenetics group of Endocrinology and Metabolism Research Institute (EMRI), various studies have been conducted to investigate the relationship between genetic markers and the risk of monogenic and complex disorders such as diabetes, obesity, thyroid malignancies, and cardiovascular disease.

Indexed as

Monogenic diseasesObesityType-1 diabetesType-2 diabetes

Identifiers

PMID39610527
PMCPMC11599698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.